Found: 16
Select item for more details and to access through your institution.
Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-020-01182-w
- By:
- Publication type:
- Article
Improved Dried Blood Spot-Based Metabolomics: A Targeted, Broad-Spectrum, Single-Injection Method.
- Published in:
- Metabolites (2218-1989), 2020, v. 10, n. 3, p. 82, doi. 10.3390/metabo10030082
- By:
- Publication type:
- Article
Metabolic features of treatment-refractory major depressive disorder with suicidal ideation.
- Published in:
- Translational Psychiatry, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41398-023-02696-9
- By:
- Publication type:
- Article
Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0057380
- By:
- Publication type:
- Article
Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0248771
- By:
- Publication type:
- Article
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.
- Published in:
- Molecular Autism, 2015, v. 6, n. 1, p. 1, doi. 10.1186/2040-2392-6-1
- By:
- Publication type:
- Article
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.
- Published in:
- Molecular Autism, 2015, v. 6, n. 1, p. 1, doi. 10.1186/2040-2392-6-1
- By:
- Publication type:
- Article
Antipurinergic therapy corrects the autism-like features in the fragile X (Fmr1 knockout) mouse model.
- Published in:
- Molecular Autism, 2015, v. 6, n. 1, p. 1, doi. 10.1186/2040-2392-6-1
- By:
- Publication type:
- Article
Cerebrospinal fluid and plasma metabolomics of acute endurance exercise.
- Published in:
- FASEB Journal, 2022, v. 36, n. 7, p. 1, doi. 10.1096/fj.202200509R
- By:
- Publication type:
- Article
Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 7, p. 491, doi. 10.1002/acn3.424
- By:
- Publication type:
- Article
Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06102-y
- By:
- Publication type:
- Article
Metabolic features of Gulf War illness.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0219531
- By:
- Publication type:
- Article
Reply to “Comment on Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial, Nutrients 2018, 10, 369”.
- Published in:
- Nutrients, 2019, v. 11, n. 5, p. 1, doi. 10.3390/nu11051138
- By:
- Publication type:
- Article
Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder--A Randomized, Controlled 12-Month Trial.
- Published in:
- Nutrients, 2018, v. 10, n. 3, p. 369, doi. 10.3390/nu10030369
- By:
- Publication type:
- Article
Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0172632
- By:
- Publication type:
- Article